A study in the Journal of the American College of Cardiology associated higher cardiac radiation doses to significantly increased odds of major adverse cardiovascular events and all-cause mortality at 20.4 months' median follow-up among individuals with non-small cell lung cancer, especially those with pre-existing coronary heart disease. The findings should prompt significant changes in radiotherapy planning guidelines and the development of a shared framework that would enable radiation oncologists, cardiologists and primary care physicians to better identify and treat CV events, as well as prevent post-radiotherapy cardiac risks, researchers wrote.
Elevated cardiac radiation dose may adversely affect NSCLC patients
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.